← Leaderboards
Joshua James Gruber
Stanford University
$1,755,145
Attributed
$1,755,145
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $638.5K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,755,145 · 2
By mechanism
R01$935,410 · 1
K08$819,735 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Michelle N Arbeitman$8,124,370
- Kenan Christopher Garcia$35,612,900
- Seung K Kim$34,748,747
- Alana M O'Reilly$4,524,214
- Ami Okada$533,784
Others in their field
Other Emerging Leaders on “Programs”
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$348,328,584
- Lynn Briscoe · Leidos Biomedical Research, Inc.$312,382,073
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
ProgramsMalignant NeoplasmsLaboratoriesPreventPropertyMouse ModelCellsImpairmentMolecularPathway InteractionsSignal TransductionTumorMutationBindingCell LineBiochemicalDrug TargetingGrowthMalignant Breast NeoplasmBasic ScienceAffectAdverse OutcomeBreast Epithelial CellsAward
Grant awards (7)
Molecular mechanisms and therapeutic principles of VISTA+ triple-negative breast cancers$460,899
R01 · FY2025 · CA · contact PI
Molecular mechanisms and therapeutic principles of VISTA+ triple-negative breast cancers$474,511
R01 · FY2024 · CA · contact PI
Metabolite sensing through the HAT1 acetyltransferase as an anti-cancer target$163,947
K08 · FY2024 · CA · contact PI
Metabolite sensing through the HAT1 acetyltransferase as an anti-cancer target$163,947
K08 · FY2023 · CA · contact PI
Metabolite sensing through the HAT1 acetyltransferase as an anti-cancer target$163,947
K08 · FY2022 · CA · contact PI
Metabolite sensing through the HAT1 acetyltransferase as an anti-cancer target$163,947
K08 · FY2021 · CA · contact PI
Metabolite sensing through the HAT1 acetyltransferase as an anti-cancer target$163,947
K08 · FY2020 · CA · contact PI